🔎 Trials Near Me

Akèy › Kansè nan tete › Texas › Lubbock

Etid klinik pou Kansè nan tete nan Lubbock, TX

6 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Lubbock (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Texas Tech University Health Sciences Center ( Site 0087), Lubbock
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center, Lubbock
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • UMC Cancer Center / UMC Health System, Lubbock
  • Texas Tech University Health Sciences Center-Lubbock, Lubbock
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • UMC Cancer Center / UMC Health System, Lubbock
  • Texas Tech University Health Sciences Center-Lubbock, Lubbock
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Ap rekriteEtid obsèvasyon
  • Joe Arrington Cancer Research & Treatment Center, Lubbock
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06401421

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Ap rekriteEtid obsèvasyon
  • Texas Tech UHSC - Southwest Cancer Center, Lubbock
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2025 · NCT03053193

Etid Kansè nan tete nan lòt vil

Lòt etid nan Lubbock

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.